Vanguard Group Inc Renovo Rx, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,345,670 shares of RNXT stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,345,670
Previous 141,487
851.09%
Holding current value
$1.88 Million
Previous $202,000
559.41%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RNXT
# of Institutions
29Shares Held
11MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.85 Million1.85% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$3.2 Million0.36% of portfolio
-
Bank Of The West975KShares$1.37 Million0.27% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL689KShares$964,0070.0% of portfolio
-
Bleichroeder LP New York, NY500KShares$700,0000.17% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $12.7M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...